EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms

Yuan Yan, Yiyao Wu, Yu Zhao, Yaguang Yang, Guangtao An, Zhidong Liu, Dongli Qi

Frontiers in Pharmacology · 23.01.2025 · 16

DOI: 10.3389/fphar.2025.1513406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.01.2025. Verfasst von Yuan Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blue light induced eye damage (BLED) belongs to modern diseases. It is an ophthalmic disease caused by prolonged exposure to electronic devices or screens containing a large amount of high-energy short waves (blue light). Specific symptoms include dryness and discomfort in the eyes, blurred vision, headache, insomnia, and in severe cases, it may also cause various eye diseases such as cataracts and glaucoma. At present, the development of health products and drugs for eye blue light injury faces many difficulties. Therefore, further exploration and research are needed on the pathogenesis, pathophysiology, and pharmacological mechanisms of blue light injury. Natural medicine ingredients and preparations have unique advantages in targeting eye blue light injury fatigue products due to their multi-component synergistic effects, overall regulation, and mild and safe characteristics. Starting from the disease-related mechanisms and pathophysiological characteristics of eye blue light injury, this article elucidates the pharmacological mechanisms of various drugs for treating eye blue light injury. At the same time, it reviews the research on in vitro cultured cell and animal model conditions for blue light injury eyes, in order to provide reference for subsequent blue light injury modeling experiments. And explore future research directions to provide new ideas and methods for the prevention and treatment of BLED.

Schlagwörter

Stichwörter der Autor:innen

blue light damageeyemodeling conditionspharmacological mechanismresearch direction

Autor:innen und Institutionen

  • Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • College of Chinese Medicine, Tianjin University of Chinese Medicine, Tianjin, China.

Zitieren

APA

Yan, Y., Wu, Y., Zhao, Y., Yang, Y., An, G., Liu, Z., & Qi, D. (2025). A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1513406

Vancouver

Yan Y, Wu Y, Zhao Y, Yang Y, An G, Liu Z, et al. A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1513406

BibTeX
@article{Yan2025,
  author = {Yan, Yuan and Wu, Yiyao and Zhao, Yu and Yang, Yaguang and An, Guangtao and Liu, Zhidong and Qi, Dongli},
  title = {A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1513406}
}
Kostenlos starten →